Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results

NEXT STORY
Allogene Therapeutics Reports First Quarter 2020 Financial Results
PREV STORY
ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous neurodegenerative diseases, including ALS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results

Strategic Focus on Growing Global Vitaros® Revenue and Achieving Profitability in 2017Apricus Granted Type ...

author_avatar
NASDAQ Market News

Solace Behavioral Health Clinic Hosts Grand Opening to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

author_avatar
NASDAQ Market News

AzurRx BioPharma Announces Completion of Enrollment in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis

author_avatar
NASDAQ Market News